Table 2. Risk factors associated with postpericardiotomy syndrome development in 58 patients referred for aortic valve surgery and/or thoracic aorta surgery.
Clinical characteristic | PPS | p value | HR (CI) | ||
---|---|---|---|---|---|
Yes n=15 |
No n=43 |
||||
Age (years), median (range) | 65 (51) | 69 (51) | 0.055 | 1.136 (0.978-1.264) | |
Gender, n (%) | Male | 8 (53) | 29 (67) | 0.328 | 0.552 (0.166-1.829) |
Female | 7 (47) | 14 (33) | |||
NYHA ≥3, n (%) | Yes | 13 (87) | 34 (79) | 0.506 | 1.721 (0.327-9.050) |
No | 2 (13) | 9 (21) | |||
LVEF <50, n (%) | Yes | 5 (33) | 8 (19) | 0.252 | 2.188 (0.584-8.189 |
No | 10 (67) | 35 (81) | |||
Coronary artery disease, n (%) | Yes | 7 (47) | 17 (39) | 0.630 | 1.338 (0.409-4.374) |
No | 8 (53) | 26 (61) | |||
Diabetes mellitus type 2, n (%) |
Yes | 3 (20) | 11 (26) | 0.659 | 0.727 (0.173-3.066) |
No | 12 (80) | 32 (74) | |||
Chronic renal insufficiency, n (%) |
Yes | 3 (20) | 7 (17) | 0.746 | 1.286 (0.286-5.774) |
No | 12 (80) | 36 (83) | |||
COPD, n (%) | Yes | 1 (7) | 2 (5) | 0.767 | 1.464 (0.123-17.145) |
No | 14 (93) | 41 (95) | |||
Urgent procedure, n (%) | Yes | 2 (13) | 0 | 0.018 | 0.867 (0.711-0.957) |
No | 13 (87) | 43 (100) | |||
CABG, n (%) | Yes | 4 (27) | 10 (23) | 0.521 | 1.2 (0.313-4.608) |
No | 11 (73) | 33 (77) | |||
Mitral valve surgery, n (%) | Yes | 0 | 2 (5) | 0.546 | 1.049 (0.982-1.120) |
No | 15 (100) | 41 (95) | |||
Fever postoperative, n (%) | Yes | 4 (27) | 1 (3) | 0.013 | 15.273 (1.547-150.765) |
No | 11 (73) | 42 (97) | |||
CRP >5 mg/L, n (%) | Yes | 13 (87) | 15 (35) | 0.001 | 12.133 (2.412-61.029) |
No | 2 (13) | 28 (65) | |||
Antibiotic postoperative, n (%) |
Yes | 7 (47) | 5 (12) | 0.004 | 6.650 (1.677-26.357) |
No | 8 (53) | 38 (88) |
PPS = postpericardiotomy syndrome; NYHA = New York Heart Association functional classification; LVEF = left ventricular ejection fraction; COPD = chronic obstructive pulmonary disease; CABG = coronary artery bypass graft; CRP = C-reactive protein